Representative Kelly Morrison (Democratic-Minnesota) recently sold shares of Accenture PLC (NYSE:ACN). In a filing disclosed on August 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in Accenture stock on August 11th. The trade occurred in the Representative’s “TRUST 1” account.
Representative Kelly Morrison also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of Accenture (NYSE:ACN) on 8/11/2026.
- Sold $1,001 – $15,000 in shares of Mobility Global (NYSE:MBGL) on 8/11/2026.
- Sold $1,001 – $15,000 in shares of Solstice Advanced Mat (NASDAQ:SOLS) on 8/11/2026.
Accenture Stock Performance
Shares of NYSE ACN opened at $181.58 on Thursday. The stock has a market capitalization of $121.26 billion, a P/E ratio of 14.50, a P/E/G ratio of 1.93 and a beta of 1.09. The firm’s 50-day moving average price is $153.25 and its two-hundred day moving average price is $178.62. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 0.15. Accenture PLC has a 52-week low of $118.15 and a 52-week high of $291.09.
Accenture announced that its board has authorized a stock buyback program on Tuesday, June 23rd that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the information technology services provider to reacquire up to 2.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.
Accenture Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 9th were issued a $1.63 dividend. The ex-dividend date of this dividend was Thursday, July 9th. This represents a $6.52 dividend on an annualized basis and a yield of 3.6%. Accenture’s dividend payout ratio is currently 52.08%.
Analyst Ratings Changes
Several research analysts have weighed in on ACN shares. Wolfe Research upped their target price on Accenture from $165.00 to $215.00 and gave the stock an “outperform” rating in a research report on Tuesday. Royal Bank Of Canada dropped their price objective on Accenture from $253.00 to $175.00 and set an “outperform” rating for the company in a report on Monday, June 22nd. Morgan Stanley cut their price objective on shares of Accenture from $177.00 to $130.00 and set an “equal weight” rating on the stock in a research report on Monday, June 22nd. Weiss Ratings cut shares of Accenture from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 9th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Accenture from $247.00 to $201.00 and set an “overweight” rating for the company in a research report on Monday, June 8th. Twelve research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $194.19.
View Our Latest Stock Analysis on Accenture
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of ACN. Triumph Capital Management bought a new position in shares of Accenture during the 3rd quarter worth approximately $26,000. Laurel Wealth Advisors LLC bought a new position in shares of Accenture in the fourth quarter worth $27,000. Dogwood Wealth Management LLC lifted its holdings in shares of Accenture by 147.1% during the 2nd quarter. Dogwood Wealth Management LLC now owns 215 shares of the information technology services provider’s stock worth $27,000 after acquiring an additional 128 shares during the last quarter. McMillan Office Inc. purchased a new stake in Accenture in the fourth quarter worth approximately $27,000. Finally, University of Texas Texas AM Investment Management Co. purchased a new stake in Accenture during the 4th quarter valued at about $27,000. Institutional investors and hedge funds own 75.14% of the company’s stock.
Insider Activity
In other news, General Counsel Joel Unruch sold 10,498 shares of the firm’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $162.98, for a total value of $1,710,964.04. Following the completion of the transaction, the general counsel owned 17,735 shares in the company, valued at $2,890,450.30. This trade represents a 37.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.02% of the stock is owned by corporate insiders.
About Representative Morrison
Kelly Morrison (Democratic Party) is a member of the U.S. House, representing Minnesota’s 3rd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
Morrison (Democratic Party) is running for re-election to the U.S. House to represent Minnesota’s 3rd Congressional District. She declared candidacy for the 2026 election.
Kelly Morrison was born in Minneapolis, Minnesota, and lives in Deephaven. Morrison earned a B.A. in history from Yale University and an M.D. from Case Western Reserve University. She completed her residency in obstetrics and gynecology at Northwestern University. Morrison’s career experience includes working as a physician.
About Accenture
Accenture is a global professional services company that provides a broad range of services and solutions in strategy, consulting, digital, technology and operations. The firm works with organizations across industries to design and implement business transformation programs, deploy and manage enterprise technology, optimize operations, and develop customer and digital experiences. Its offerings encompass management and technology consulting, systems integration, application and infrastructure services, cloud migration and managed services, as well as security and analytics capabilities.
The company delivers industry- and function-specific solutions, combining consulting expertise with proprietary tools, platforms and partnerships with major technology vendors.
Further Reading
- Five stocks we like better than Accenture
- Is Quantinuum Emerging as a Leader in the Quantum Race?
- J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
